U.S. Markets closed
  • S&P Futures

    3,437.25
    -14.50 (-0.42%)
     
  • Dow Futures

    28,070.00
    -119.00 (-0.42%)
     
  • Nasdaq Futures

    11,617.75
    -45.75 (-0.39%)
     
  • Russell 2000 Futures

    1,625.20
    -10.40 (-0.64%)
     
  • Crude Oil

    39.13
    -0.72 (-1.81%)
     
  • Gold

    1,898.00
    -7.20 (-0.38%)
     
  • Silver

    24.44
    -0.23 (-0.95%)
     
  • EUR/USD

    1.1847
    +0.0021 (+0.1777%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • Vix

    27.55
    -0.56 (-1.99%)
     
  • GBP/USD

    1.3047
    -0.0033 (-0.2531%)
     
  • USD/JPY

    104.7230
    -0.1170 (-0.1116%)
     
  • BTC-USD

    13,034.63
    +17.11 (+0.13%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,516.59
    +42.29 (+0.18%)
     

Standard Motor (SMP) Posts In Line Q1 Earnings, Halts Payout

Zacks Equity Research
·3 mins read

Standard Motor Products Inc. SMP reported adjusted earnings of 43 cents per share in first-quarter 2020, in line with the Zacks Consensus Estimate. However, the bottom line came in higher than the prior-year quarter’s 57 cents per share. Dismal performance of both its major segments — Engine Management and Temperature Control — acted as dampeners.

First-quarter earnings from continuing operations were $9.6 million compared with $13.1 million recorded in the prior-year quarter. Total revenues decreased to $254.3 million, missing the Zacks Consensus Estimate of $256 million. The tally also came in lower than the year-ago figure of $283.8 million.

Gross profit decreased to $70.4 million from the year-ago quarter’s $77.9 million. Operating income slid to $14.3 million from $17.9 million recorded in the year-ago quarter.

Segmental Results

During the March quarter, revenues from the Engine Management segment fell 5.6% year on year to $201.1 million. Operating income was $21.6 million compared with $22.3 million in the prior-year quarter. Lower pipeline orders and weak sales amid the COVID-19 pandemic affected the segment’s performance.

Revenues in the Temperature Control segment decreased 25.3% year over year to $51.4 million. The segment incurred an operating loss of $348,000 against operating income of $2.05 million in first-quarter 2019.

Revenues in the All Other segment decreased to $2.54 million from the $2.83 million recorded in the prior-year quarter. The segment reported an operating loss of $6.7 million, wider than loss of $6.4 million in corresponding quarter of 2019.

Financial Position 

Standard Motor had cash and cash equivalents of $13.3 million as of Mar 31, 2020, compared with $10.4 million as of Dec 31, 2019. Long-term debt was $111,000 compared with $129,000 recorded as of Dec 31, 2019. Net cash used in operating activities totaled $32.8 million. Capex during the quarter amounted to $4.4 million.

Cost-Cut Actions Amid COVID-19

In a bid to boost financial flexibility amid coronavirus-led uncertainty, the firm has drawn down an additional $75 million from its bank credit line. Standard Motor has also suspended its quarterly payouts and stock buyback programs. It also intends to tighten discretionary capex and anticipates achieving substantial savings from the above-mentioned cost-cut efforts. The company would slash 25% salary of its top executives and board of directors.

Zacks Rank & Key Picks

Standard Motor currently carries a Zacks Rank #3 (Hold).

Investors interested in auto stocks can consider Modine Manufacturing Company MOD, Unique Fabricating, Inc. UFAB and Veoneer, Inc. VNE, each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Standard Motor Products, Inc. (SMP) : Free Stock Analysis Report
 
Modine Manufacturing Company (MOD) : Free Stock Analysis Report
 
Unique Fabricating, Inc. (UFAB) : Free Stock Analysis Report
 
Veoneer, Inc. (VNE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research